Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1707 results
A medical professional drawing a dose of a vaccine from a vial with a syringe

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service

by Jacob Smith | News | 31 May 2024

31 May 2024

Anna Housley and her husband Tom. The BCAN-RAY project found that Anna has an increased risk of developing breast cancer. She now gets yearly mammograms.

One year in, the research project launched in memory of Sarah Harding is identifying younger women who may have a higher breast cancer risk. One year in, the research project launched in memory of Sarah Harding is identifying younger women who may have a higher breast cancer risk.

by Tim Gunn | News | 30 May 2024

30 May 2024

This entry is part 18 of 38 in the series That Cancer Conversation
%postcontent%
An abstract illustration of a DNA molecule

Researchers from the Cancer Grand Challenges Mutographs team have identified a previously unknown mutational signature in the DNA of kidney cancer across 11 countries Researchers from the Cancer Grand Challenges Mutographs team have identified a previously unknown mutational signature in the DNA of kidney cancer across 11 countries

by Jacob Smith | In depth | 1 May 2024

1 May 2024

Vaccine vial and needle

Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials

by Iain Foulkes | Opinion | 26 April 2024

26 April 2024

A medical professional holding a tube containing a blood sample

Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary. Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary.

by Jacob Smith | In depth | 23 April 2024

23 April 2024

Professor Iain McNeish

Clinician scientists are vital in bridging the gap between discovery research and the patient. So how do we continue to attract medics to research? Clinician scientists are vital in bridging the gap between discovery research and the patient. So how do we continue to attract medics to research?

by Phil Prime | Interview | 5 April 2024

5 April 2024

This entry is part 12 of 17 in the series Research Integrity
%postcontent%
Several disposable e-cigarettes in different colours

You may have seen media coverage of a study that looked at changes in different types of cells from people who smoked and people who vaped. Let's break down what the results really show. You may have seen media coverage of a study that looked at changes in different types of cells from people who smoked and people who vaped. Let's break down what the results really show.

by Julia Cotterill | Analysis | 20 March 2024

20 March 2024

A male patient with a female doctor during an appointment

Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed

by Jacob Smith | News | 14 March 2024

14 March 2024